Peanut allergy: Skin patch therapy ‘boosts tolerance’ in toddlers

Though results are promising, its role in clinical care is unclear, says allergy and respiratory physician Dr Celia Zubrinich.
Rachel Fieldhouse
Child with peanuts

Two-thirds of toddlers with peanut allergy had improved tolerance when treated with epicutaneous immunotherapy, according to results from an international study involving Australian children.

After 12 months, 64% of children given the skin patch containing 250µg of peanut protein could tolerate a 1000mg food challenge, regardless of baseline severity, compared to just 30% of those given placebo.